Novaliq pursues EMA approval for dry eye disease drug
The EMA accepted Novaliq’s marketing authorisation application for cyclosporine eye drops, following FDA approval.
The EMA accepted Novaliq’s marketing authorisation application for cyclosporine eye drops, following FDA approval.
What's Your Reaction?
